2020-07-28 | Purchase | Inozyme Pharma, Inc. INZY | 10 percent owner | | $16.00 | $2.6M | +19.03% | |
2020-06-09 | Sale | Regeneron Pharmaceuticals, Inc. REGN | 10 percent owner | | $597.48 | $71.84M | -14.96% | |
2020-05-29 | Sale | Regeneron Pharmaceuticals, Inc. REGN | 10 percent owner | | $509.85 | $11.64B | -13.71% | |
2020-03-09 | Sale | Regeneron Pharmaceuticals, Inc. REGN | 10 percent owner | | $489.65 | $63.12M | +17.75% | |
2019-09-10 | Sale | Regeneron Pharmaceuticals, Inc. REGN | 10 percent owner | | $281.15 | $48.61M | +62.68% | |
2019-07-22 | Purchase | Fulcrum Therapeutics, Inc. FULC | 10 percent owner | | $16.00 | $3M | +2.11% | |
2019-03-08 | Sale | Regeneron Pharmaceuticals, Inc. REGN | 10 percent owner | | $412.17 | $54.04M | -19.49% | |
2018-09-06 | Sale | Regeneron Pharmaceuticals, Inc. REGN | 10 percent owner | | $406.68 | $42.52M | -9.36% | |
2018-06-08 | Sale | Regeneron Pharmaceuticals, Inc. REGN | 10 percent owner | | $309.31 | $37.61M | +21.88% | |
2017-08-24 | Purchase | Regeneron Pharmaceuticals, Inc. REGN | 10 percent owner | | $482.04 | $51.01M | -24.23% | |
2017-08-23 | Purchase | Regeneron Pharmaceuticals, Inc. REGN | 10 percent owner | | $478.98 | $29.02M | -22.94% | |
2017-06-02 | Purchase | Regeneron Pharmaceuticals, Inc. REGN | 10 percent owner | | $478.17 | $65.06M | -19.84% | |
2017-05-31 | Purchase | Alnylam Pharmaceuticals, Inc. ALNY | 10 percent owner | | $71.87 | $42.76M | +75.06% | |
2016-06-14 | Purchase | Regeneron Pharmaceuticals, Inc. REGN | 10 percent owner | | $363.86 | $23.55M | +4.19% | |
2016-02-17 | Purchase | Regeneron Pharmaceuticals, Inc. REGN | 10 percent owner | | $393.71 | $31.5M | -3.34% | |
2016-02-16 | Purchase | Regeneron Pharmaceuticals, Inc. REGN | 10 percent owner | | $391.23 | $31.75M | -1.92% | |
2016-02-01 | Purchase | Alnylam Pharmaceuticals, Inc. ALNY | 10 percent owner | | $69.75 | $28.6M | -14.22% | |
2016-01-12 | Purchase | Regeneron Pharmaceuticals, Inc. REGN | 10 percent owner | | $465.04 | $39.03M | -17.81% | |
2015-11-16 | Purchase | Voyager Therapeutics, Inc. VYGR | | | $14.00 | $3.5M | -30% | |
2015-10-06 | Purchase | Regeneron Pharmaceuticals, Inc. REGN | 10 percent owner | | $461.23 | $42.24M | -11.87% | |